Health
-

Grand Forks Carbon Monoxide Awareness: The Silent Winter Danger
Grand Forks marks National Carbon Monoxide Awareness Month as winter approaches, shedding light on a silent, invisible danger. From detectors that save lives to simple preventive steps, this reminder emphasizes quick actions to stay safe when the cold sets in.
-

Could Access to Work Change Your Work Life?
Facing workplace hurdles due to health or disability? A long-running government program offers tailored support—grants for equipment, travel, and workplace adjustments—designed to help you start or stay in paid work. Learn who may qualify and what kind of help could be on offer.
-

Meghan Trainor’s Weight-Loss Lesson: Strength Training Beats Medication Alone
Meghan Trainor’s post-pregnancy journey is reigniting the conversation about how medicine and movement work together for real results. Fitness pros highlight strength work, smart nutrition, and steady consistency as the true drivers—sometimes more than the meds alone. A holistic approach to weight loss might be the lasting answer.
-

Chris Hemsworth’s Road Trip to Remember: A Personal Take on Memory and Connection
Chris Hemsworth takes a deeply personal road trip across Australia with his father, turning memory, love, and breathtaking landscapes into a meaningful journey. A one-hour look at reminiscence, social connection, and the power of shared moments to light a path through memory loss.
-

Long-Term Melatonin Use Linked to Higher Heart Failure Risk, Study Finds
New analysis raises questions about the long-term safety of melatonin, the popular sleep aid. Early findings hint at risks linked to extended use, including heart-related issues and overall mortality, prompting experts to call for more research. As melatonin grows in popularity, scientists say it’s time to reassess guidance on its use.
-

Long-Term Melatonin Use Linked to Higher Heart Failure Risk
Long-term melatonin use for chronic insomnia may carry unseen heart-health risks. Emerging findings suggest a possible link to heart-related problems and related hospitalizations, underscoring the need for careful use and more research.
-

Kids Face Higher, Longer-Lasting Heart Risks After COVID Infection Than Vaccination
A new large-scale study finds that COVID-19 infection in children and teens carries a higher and longer-lasting risk of rare heart and inflammatory issues than vaccination. Vaccine-related risks appear brief, while infection-related risks can persist for months. The findings, based on health records from millions of young people, shed new light on the long-term implications…
-

Gaza Vaccination Campaign Aims to Protect Children Amid Conflict
In Gaza, a high-stakes vaccination drive seeks to shield children from deadly, vaccine-preventable diseases as conflict disrupts routine care. A coalition of international partners mobilizes in phases to reach the most vulnerable, offering a glimmer of hope for a generation under siege.
-

Pfizer Faces Fall COVID-19 Vaccine Slump as Health Guidance Shifts
Fall’s vaccination season is facing headwinds as Pfizer’s COVID shot sales slip amid new guidance and questions about necessity. Late arrival of updated vaccines and mixed public sentiment are reshaping uptake, with experts warning the downturn could extend to other vaccines.
-

Measles Resurgence Prompts Scrutiny of the Hidden Vaccine Exemption Industry
Measles is making a scary comeback as vaccine skepticism stretches from people to pets. A new wave of waivers and exemptions is drawing attention to a murky intersection of health, policy, and belief. In a world of misinformation, trusted medical guidance and public education become the frontline defense.
-

India’s Obesity Crisis and the GLP-1 Drug Debate: Mounjaro and Semaglutide in Focus
India faces a growing obesity crisis that touches every corner of society. The emergence of GLP-1 weight-loss drugs is prompting urgent questions about medical solutions, cost, and ethics, while experts caution that lasting change still hinges on diet and lifestyle. The conversation highlights a complex balance between innovation and equity in health.
-

Lawmakers Push Back on CMS Plan to Limit Diabetes Tech Coverage
A bipartisan group of lawmakers challenges CMS’s proposal to curb access to essential diabetes devices—CGMs and insulin pumps—warning that a one-size-fits-all approach could limit care. They urge reevaluation toward patient-centered, evidence-based coverage.
-

Amanda Bynes Shares Ozempic-Driven Weight Loss Update
Amanda Bynes offers a hopeful update on her weight‑loss journey with Ozempic, revealing she’s down 20 pounds and aiming for 15 more. She says the medication is really working for her and helping curb cravings as she pursues a leaner, healthier look. The post also touches on mental health and the routines she’s leaning on…
-

Ultra-Processed Foods Linked to Higher Diabetes Risk in Women
Emerging research links ultraprocessed foods to weight gain and a higher risk of type 2 diabetes, even for those who eat well overall. The findings highlight a potential need for stronger dietary guidance and broader changes to the food supply.
-

WHO warns external health aid could fall by up to 40% by 2025, urging LMICs to mobilize domestic funding
External health aid is expected to drop sharply, putting essential services in LMICs at risk. As gaps emerge in maternal care, vaccines, and disease surveillance, countries are turning inward—exploring domestic funding and urgent financing strategies to keep health systems resilient.
-

Obamacare 2026 Premium Surge as Subsidies End
With pandemic-era subsidies ending, Obamacare premiums are poised to rise—and the impact could ripple across households nationwide. As enrollment opens, many face tough choices and policymakers scramble for relief. This look at who’s most at risk and why the changes matter could reshape how you think about coverage.
-

Preliminary Melatonin Findings Spark Questions About Heart Failure Risk
Could long-term melatonin use affect heart health? A large, preliminary study hints at an association with higher rates of heart failure and mortality among chronic insomnia patients, but experts warn the findings are early and not peer-reviewed. As the sleep-heart health puzzle remains complex, clinicians urge caution and more rigorous research before drawing conclusions.
-

Hims & Hers Bets on GLP-1 Microdosing Amid Novo Nordisk Tensions
Hims & Hers is testing GLP-1 microdosing to broaden metabolic-health options beyond weight loss, using lower doses for a more personalized approach. The move hints at greater accessibility and new treatment strategies, even as regulatory and competitive tensions unfold. A glimpse into where metabolic therapies might be headed next.
-

FDA questions AMT-130 data as uniQure reevaluates Huntington’s BLA path
An unexpected regulatory shift casts doubt on the data backing uniQure’s Huntington’s gene therapy AMT-130, clouding the timeline for a potential BLA submission. The company is pursuing next steps with regulators in the US and abroad, keeping patient access at the forefront.
-

Huntington’s Disease: Breakthroughs, Diagnosis Gaps, and a Wave of Hope
October brought fresh momentum to Huntington’s disease research—DNA repair strategies, sharper insights into diagnosis gaps, and robust discussions at the Huntington’s Disease Clinical Research Congress 2025. Early biomarker work and new trial ideas are tightening the HD map, while strong community support keeps the science advancing.
-

Deadly Listeria Outbreak Tied to Recalled Pasta Meals, CDC Says
A serious listeria outbreak tied to prepared pasta meals is prompting a nationwide public health effort. As investigators race to pinpoint the source and recalls roll out, what this could mean for your kitchen remains unfolding.